Metabolic fate of ultratrace levels of GeCl4 in the rat and in vitro studies on its basal cytotoxicity and carcinogenic potential in Balb/3T3 and HaCaT cell lines

Journal of Applied Toxicology

Volumn 30, Issue 1, 2010, Pages 34-41

  Sabbioni, E ^a   Fortaner, S ^b   Bosisio, S ^c   Farina, M ^b   Del Torchio, R ^b   Edel, J ^c   Fischbache, M ^d  

^a UNIVERSITY OF CHIETI   (Italy)

^b JOINT RESEARCH CENTRE   (Italy)

^c ABICH Srl ^*  (Italy)

^d ABICH Srl   (Italy)

Author keywords

Balb 3T3; Carcinogenic potential; Cytotoxicity; Germanium; HaCaT; Metabolic patterns; Rats

Indexed keywords

GERMANIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; CHROMATOGRAPHY; CONTROLLED STUDY; CYTOSOL; CYTOTOXICITY; ERYTHROCYTE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; KIDNEY CELL; LIVER CELL; MALE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; ULTRAFILTRATION; URINARY EXCRETION;

3T3 CELLS; ANIMALS; CARCINOGENICITY TESTS; CARCINOGENS; CELL LINE; FIBROBLASTS; GERMANIUM; HUMANS; KERATINOCYTES; MALE; MICE; MICE, INBRED BALB C; RATS; RATS, SPRAGUE-DAWLEY; SKIN; TISSUE DISTRIBUTION;

MUS; RATTUS;

EID: 74549152676     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1469     Document Type: Article

References (37)

1. Bertolero F, Sabbioni E, Edel J, Pietra R. 1987. Quantitative studies on cytotoxicity and neoplastic transformation of Balb/3T3 cells by trace metals. In Proceedings, Occupational and Environmental Chemical Hazards, Colombi A, Ennet EA, Foà V, Maroni M (eds). Ellis Horwood: Chichester; 478-483.
2. Celis A, Celis JE. 1998. In: Cell Biology. A Laboratory Handbook, 2nd edn, Celis JE (ed.). Academic Press: San Diego CA; 11-12.
3. Chiu HW, Kauzlarich SM, Sutter E. 2006. Thermal behaviour and film formation from an organogermanium polymer/nanoparticle precursor. Langmuir 22: 5455-5458.
4. Chiu SJ, Lee MY, Chen HW, Chou WG, Lin LY. 2002. Germanium oxide inhibits the transition from G2 to M phase of CHO cells. Chem. Biol. Interact. 141: 211-228.
5. Combes R, Balls M, Curren R, Fischbach M, Fusenig N, Kirkland D, Lasne C, Landolph J, LeBoeuf R, Marquardt H, McCormick J, Müller L, Rivedal E, Sabbioni E, Tanaka N, Vasseur P, Yamasaki H. 1999. Cell Transformation Assays as Predictors of Human Carcinogenicity. The Report and Recommendations of ECVAM Workshop 39, ATLA Vol. 27; 745-767.
6. Dudley HC, Wallace EJ. 1952. Pharmacological studies of radiogermanium (GE71). AMA Arch. Ind. Hyg. Occup. Med. 6: 263-270.
7. Fusenig N, Boukamp P. 1998. Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes. Mol. Carcinogen 23: 144-158.
8. Gerber GB. 1988. Handbook on Toxicity of Inorganic Compounds, Seiler HG, Seilerand H, Siegel A (eds). Marcel Dekker: New York; 301.
9. Gerber GB, Léonard A. 1997. Mutagenicity, carcinogenicity and teratogenicity of germanium compounds. Mutat. Res. 387: 141-146.
10. Gray's Anatomy, 38th edn. 1995. Churchill Livingstone: Edinburgh.
11. Hamilton EI, Minski M J, Cleary J J. 1972. The concentration and distribution of some stable elements in healthy human tissues from the United Kingdom. Sci. Total Environ. 1: 341-374.
12. Higuchi I, Takahashi K, Nakahara K, Izumo S, Nakagawa M, Osame M. 1991. Experimental germanium myopathy. Acta Neuropathol. 82: 55-59.
13. Kamijo M,Yagihashi S, Kida K, Narita S, Nakata F. 1991. An autopsy case of chronic germanium intoxication presenting peripheral neuropathy, spinal ataxi and chronic renal failure. Clin. Neurol. 31: 191-196.
14. Kanematsu K, Kada T. 1978. Mutagenicity of metal compounds. Mutat. Res. 53: 207-208.
15. Kanisawa M, Schroeder H. 1967. Life term studies on the effects of arsenic, germanium, tin and vanadium on spontaneous tumours in mice. Cancer Res. 27: 1192-1195.
16. Lin CH, Chen TJ, Hsieh YL, Jiang SJ, Chen SS. 1999. Kinetics of germanium dioxide in rats. Toxicology 132: 147-153.
17. Lin CH, Chen SS, Lin YC, Lee YS, Chen TJ. 2006. Germanium dioxide induces mitochondria-mediated apoptosis in Neuro-2A cells. Neurotoxicology 27: 1052-1063.
18. Matsumuro K, Izumo S, Higuchi I, Ronquillo AT, Takahashi K, Osame M. 1993. Experimental germanium dioxide-induced neuropathy in rats. Acta Neuropathol. 86(6): 547-553.
19. McMahon T, Regan M, Hughes F. 2006.The determination of total germanium in real food samples including Chinese herbal remedies using graphite furnace atomic absorption spectroscopy. Food Chem. 97: 411-417.
20. Mehard CW, Volcani B E. 1975. Similarity in uptake and retention of trace amounts of 31 silicon and 68 germanium in rat tissues and cell organelles. Bioinorg. Chem. 5: 107-124.
21. Nagata N, Yoneyama T, Yanagida K. 1985. Accumulation of germanium in the tissues of a long-term user of germanium preparation dead of acute renal failure. J. Toxicol. Sci. 10: 333-341.
22. 99mTc-labeled organogermanium nanoparticles and their in vivo study as a spleen imaging agent. J. Labelled Comp. Radiopharm. 49: 1163-1170.
23. Roels HA, Buchet JP. 2001. Determination of germanium in urine and its usefulness for biomonitoring of inhalation exposure to inorganic germanium in the occupational setting. J. Environ. Monit. 3: 67-73.
24. Sabbioni E, Marafante E. 1976. Identification of lead-binding components in rat liver: in vivo study. Chem. Biol. Interact. 15: 1-20.
25. Sabbioni E, Pozzi G, Pintar A, Casella L, Garattini S. 1991. Cellular retention, cytotoxicity and morphological transformation by vanadium(IV) and vanadium(V) in BALB/3T3 cell lines. Carcinogenesis 12: 47-52.
26. Sabbioni E, Ponti J, Del Torchio R, Farina M, Fortaner S, Munaro B, Sasaki T, Rossi F. 2006. Recherche in vitro sur la toxicologie des nanoparticules au Joint Research Center. Méd. Nucl. Imag. fonct. métab. 30: 15-23.
27. Sanai T, Oochi N, Okuda S, Osato S, Kiyama S, Komota T, Onoyama K, Fujishima M. 1990. Subacute nephrotoxicity of germanium dioxide in the experimental animal. Toxicol. Appl. Pharmacol. 103: 345-353.
28. Sanai T, Okuda S, Onoyama K, Oochi N, Takaichi S, Mizuhira V, Fujishima M. 1991. Chronic tubulointerstitial changes induced by germanium dioxide in comparison with carboxyethylgermanium sesquoxide. Kidney Int. 40: 882-890.
29. Schauss AG. 1991. Nephrotoxicity and neurotoxicity in humans from organogermanium compounds and germanium dioxide. Biol. Trace Element Res. 29: 267-280.
30. Seaborn CD, H Nielsen F. 1994. Effects of germanium and silicon on bone mineralization. Biol. Trace Element Res. 42: 151-164.
31. Segura RA, Reyes-Gasga J, Cárdenas-Triviño G. 2005. Germanium nanoparticles from solvated atoms: synthesis and characterization. Colloid Polym. Sci. 283: 854-861.
32. Shinogi M, Masaki T, Mori I. 1989. Determination and biokinetics of germanium in mouse tissues by atomic absorption spectrometry with electrothermal atomization. J. Trace Elem. Electrolytes Health Dis. 3: 25-28.
33. Suzuki F, Brutkiewicz RR, Pollard RB. 1985. Importance of T-cells and macrophages in the antitumour activity of carboxyethylgermanium sesquioxide (Ge-132). Anticancer Res. 5: 479-483.
34. Suzuki F, Brutkiewicz RR, Pollard RB. 1986. Cooperation of lymphokine(s) and macrophages in expression of antitumor activity of carboxyethylgermanium sesquioxide (Ge-132). Anticancer Res. 6: 177-182.
35. Tao SH, Bolger PM. 1997. Hazard assessment of germanium supplement. Regul. Toxicol. Pharmacol. 25: 211-219.
36. Takeuchi A, Yoshizawa N, Oshima S, Kubota T, Oshikawa Y, Akashi Y, Oda T, Niwa H, Imazeki N, Seno A, Fuse Y. 1992. Nephrotoxicity of germanium compounds: report of a case and review of the literature. Nephron 60: 436-442.
37. Yim SY, Lee I Y, Kim T S. 1999. Enzyme histochemical study of germanium dioxide-induced mitochondrial myopathy in rats. Yonsei Med. J. 40: 69-75.